AI Reputation Analysis and Signal Evaluation – LIXIANA (Daiichi Sankyo)

B
Reputation Level
Medical Devices, Pharma & Biotech
59.3 Avg Reputation

Based on 784 businesses audited.

Brand AI Reputation

Medical Devices, Pharma & Biotech Reputation: LIXIANA (Daiichi Sankyo) (lixiana.com)

https://lixiana.com 📍 Industry: Medical Devices, Pharma & Biotech
84 Reputation / 100

LIXIANA® delivers a clinic-first digital presence that is nearly devoid of typical marketing bullshit. It leverages hard data, peer-reviewed citations, and rigorous trial parameters to build authority, though its technical SEO implementation lags behind its clinical sophistication.

Info Density Power-words vs. Substance ratio.
25 83% Reputation
View evidence →
Semantic Coherence Homepage promise vs. Sub-page reality.
20 100% Reputation
View evidence →
Trust & Proof Verifiable evidence vs. Trust Theatre.
18 90% Reputation
View evidence →
Commodity Fingerprint Detection of industry clichés/templates.
11 73% Reputation
View evidence →
Identity & Authority Expert verifiability & Schema depth.
10 67% Reputation
View evidence →

Medical Devices, Pharma & Biotech Reputation: LIXIANA (Daiichi Sankyo) (lixiana.com)

Reputation: 84 / 100

The content perfectly aligns with the Pharmaceutical and Biotech category, specifically focusing on anticoagulation therapy. The use of clinical trial nomenclature (ENGAGE AF-TIMI 48, Hokusai-VTE) and rigorous inclusion/exclusion criteria confirms its status as a professional healthcare resource.

“The low score of 84 is driven by the extreme information density and total lack of semantic drift. The few points deducted originate from the aging nature of the primary trial evidence (2013 data being stale by May 2026 standards) and the technical absence of structured schema data to support the brand's authority.”

Verified Analysis Date: May 25, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result